A review of pulmonary toxicity of electronic cigarettes in the context of smoking: a focus on inflammation
PG Shields, M Berman, TM Brasky… - … Biomarkers & Prevention, 2017 - AACR
The use of electronic cigarettes (e-cigs) is increasing rapidly, but their effects on lung toxicity
are largely unknown. Smoking is a well-established cause of lung cancer and respiratory …
are largely unknown. Smoking is a well-established cause of lung cancer and respiratory …
Psoriasis and respiratory comorbidities: the added value of fraction of exhaled nitric oxide as a new method to detect, evaluate, and monitor psoriatic systemic …
P Santus, M Rizzi, D Radovanovic… - BioMed Research …, 2018 - Wiley Online Library
Psoriasis is a chronic inflammatory systemic disease characterized by a wide range of
comorbidities. Respiratory comorbidities are currently poorly characterized and with …
comorbidities. Respiratory comorbidities are currently poorly characterized and with …
Reference values of fractional excretion of exhaled nitric oxide among non-smokers and current smokers
K Torén, N Murgia, L Schiöler, B Bake… - BMC pulmonary medicine, 2017 - Springer
Background Fractional exhaled nitric oxide (FE NO) is used to assess of airway
inflammation; diagnose asthma and monitor adherence to advised therapy. Reliable and …
inflammation; diagnose asthma and monitor adherence to advised therapy. Reliable and …
Differential effect of cigarette smoke exposure on exhaled nitric oxide and blood eosinophils in healthy and asthmatic individuals
Background: Tobacco smoking affects both the fraction of exhaled nitric oxide (FeNO) and
blood eosinophil (B-Eos) count, two clinically useful biomarkers in respiratory disease that …
blood eosinophil (B-Eos) count, two clinically useful biomarkers in respiratory disease that …
Basic characteristics and clinical value of FeNO in smoking asthmatics—a systematic review
A Ahovuo-Saloranta, P Csonka… - Journal of breath …, 2019 - iopscience.iop.org
Fractional exhaled nitric oxide (FeNO) reflects eosinophilic airway inflammation and it can
be used to diagnose and phenotype asthma and predict treatment responses. However …
be used to diagnose and phenotype asthma and predict treatment responses. However …
[HTML][HTML] Bronchodilator response and lung function decline: Associations with exhaled nitric oxide with regard to sex and smoking status
E Nerpin, DS Ferreira, J Weyler, V Schlunnsen… - World Allergy …, 2021 - Elsevier
Background Fractional exhaled nitric oxide (FeNO) is a marker of type-2 inflammation used
both to support diagnosis of asthma and follow up asthma patients. The associations of …
both to support diagnosis of asthma and follow up asthma patients. The associations of …
Determinants of fractional exhaled nitric oxide in healthy men and women from the European Community Respiratory Health Survey III
E Nerpin, M Olivieri, T Gislason, AC Olin… - Clinical & …, 2019 - Wiley Online Library
Introduction The fractional exhaled nitric oxide (FENO) is a marker for type 2 inflammation
used in diagnostics and management of asthma. In order to use FENO as a reliable …
used in diagnostics and management of asthma. In order to use FENO as a reliable …
[HTML][HTML] Importance of type and degree of IgE sensitisation for defining fractional exhaled nitric oxide reference values
S Zaigham, X Zhou, M Molin, A Sjölander… - Respiratory …, 2021 - Elsevier
Background Fractional exhaled nitric oxide (FE NO) is a marker of type 2 airway
inflammation used in clinical practice in asthma. However, reference values are needed to …
inflammation used in clinical practice in asthma. However, reference values are needed to …
Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products
MJ Peck, EB Sanders, G Scherer, F Lüdicke… - Biomarkers, 2018 - Taylor & Francis
Context: One approach to reducing the harm caused by cigarette smoking, at both individual
and population level, is to develop, assess and commercialize modified risk alternatives that …
and population level, is to develop, assess and commercialize modified risk alternatives that …
Biomarkers for differentiation of patients with asthma and chronic obstructive pulmonary disease
Objective: Asthma and chronic obstructive pulmonary disease (COPD) are airflow limitation
diseases with similar clinical manifestations but different pathophysiologic mechanisms. To …
diseases with similar clinical manifestations but different pathophysiologic mechanisms. To …